Akm E. Ullah

Array ( [id] => 11994300 [patent_doc_number] => 20170298455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'COMPOSITION AND METHOD FOR IMAGING STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/631124 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9785 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14655621 [patent_doc_number] => 20190234939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Juvenile Atopic Dermatitis Models [patent_app_type] => utility [patent_app_number] => 16/311378 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14535265 [patent_doc_number] => 20190203254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/322545 [patent_app_country] => US [patent_app_date] => 2017-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11037 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14310409 [patent_doc_number] => 20190144908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => HIGH CELL DENSITY ANAEROBIC FERMENTATION FOR PROTEIN EXPRESSION [patent_app_type] => utility [patent_app_number] => 16/308267 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14930449 [patent_doc_number] => 20190300862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => Herpesvirus with Modified Glycoprotein H for Propagation in a Cell [patent_app_type] => utility [patent_app_number] => 16/307708 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979615 [patent_doc_number] => 20170283769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'Modified Cells Evoking Reduced Immunogenic Responses' [patent_app_type] => utility [patent_app_number] => 15/616787 [patent_app_country] => US [patent_app_date] => 2017-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12580776 [patent_doc_number] => 20180085421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-29 [patent_title] => Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent [patent_app_type] => utility [patent_app_number] => 15/609605 [patent_app_country] => US [patent_app_date] => 2017-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14567421 [patent_doc_number] => 20190211317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES [patent_app_type] => utility [patent_app_number] => 16/305003 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92689 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15130175 [patent_doc_number] => 10478524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-19 [patent_title] => Tissue-engineered silk organs [patent_app_type] => utility [patent_app_number] => 15/600351 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 27 [patent_no_of_words] => 8393 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16446034 [patent_doc_number] => 10837957 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-17 [patent_title] => In vitro model for pathological or physiologic conditions [patent_app_type] => utility [patent_app_number] => 15/599821 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 74 [patent_no_of_words] => 31763 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11949783 [patent_doc_number] => 20170253934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'METHOD FOR SCREENING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 15/600068 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11357 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17800210 [patent_doc_number] => 11414491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Targeting PD-L1 on tumor cells [patent_app_type] => utility [patent_app_number] => 16/302403 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 18130 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17513900 [patent_doc_number] => 11293033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-05 [patent_title] => Compositions and methods for genomic integration of nucleic acids into exogenous landing pads [patent_app_type] => utility [patent_app_number] => 16/302079 [patent_app_country] => US [patent_app_date] => 2017-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 35 [patent_no_of_words] => 37509 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14306539 [patent_doc_number] => 20190142973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A [patent_app_type] => utility [patent_app_number] => 16/098660 [patent_app_country] => US [patent_app_date] => 2017-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14581813 [patent_doc_number] => 20190218515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => EX VIVO BITE-ACTIVATED T CELLS [patent_app_type] => utility [patent_app_number] => 16/093867 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11758522 [patent_doc_number] => 20170205391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS' [patent_app_type] => utility [patent_app_number] => 15/478041 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 19968 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14360663 [patent_doc_number] => 10301619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Compositions and methods relating to synthetic RNA polynucleotides created from synthetic DNA oligonucleotides [patent_app_type] => utility [patent_app_number] => 15/469681 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 34 [patent_no_of_words] => 11323 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14407651 [patent_doc_number] => 20190169669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => PHEROMONAL RECEPTOR OF SPODOPTERA LITTORALIS AND IDENTIFICATION OF NATURAL LIGAND OF SAID RECEPTOR AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/087312 [patent_app_country] => US [patent_app_date] => 2017-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14159289 [patent_doc_number] => 20190106747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => DRUGS, PHARMACOGENOMICS AND BIOMARKERS FOR ACIVE LONGEVITY [patent_app_type] => utility [patent_app_number] => 16/087465 [patent_app_country] => US [patent_app_date] => 2017-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17815665 [patent_doc_number] => 11421264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Thiol-containing cleave reagents and oxidative wash [patent_app_type] => utility [patent_app_number] => 15/457344 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 124 [patent_no_of_words] => 40875 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 301 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15457344 [rel_patent_id] =>[rel_patent_doc_number] =>)